Teleflex Incorporated (NYSE:TFX) Shares Sold by Davis R M Inc.

Davis R M Inc. lowered its position in shares of Teleflex Incorporated (NYSE:TFX) by 43.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,271 shares of the medical technology company’s stock after selling 1,765 shares during the quarter. Davis R M Inc.’s holdings in Teleflex were worth $562,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in TFX. Cromwell Holdings LLC grew its stake in Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after acquiring an additional 49 shares in the last quarter. Avior Wealth Management LLC lifted its holdings in Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares during the last quarter. Ashton Thomas Securities LLC purchased a new position in shares of Teleflex during the 3rd quarter worth $40,000. Canada Pension Plan Investment Board acquired a new stake in shares of Teleflex during the 2nd quarter worth about $42,000. Finally, GAMMA Investing LLC raised its holdings in Teleflex by 131.1% in the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock valued at $42,000 after buying an additional 97 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Trading Up 1.5 %

Shares of Teleflex stock opened at $194.60 on Tuesday. The company has a 50-day moving average of $223.96 and a two-hundred day moving average of $222.96. Teleflex Incorporated has a 12-month low of $185.66 and a 12-month high of $257.85. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a market cap of $9.04 billion, a PE ratio of 38.69, a price-to-earnings-growth ratio of 1.96 and a beta of 1.18.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.64 EPS. On average, research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.70%. Teleflex’s dividend payout ratio is currently 27.04%.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of recent analyst reports. Stephens lifted their price target on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Mizuho decreased their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Truist Financial reaffirmed a “hold” rating and issued a $227.00 price objective (down from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Friday, November 1st. Four analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $259.25.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.